Invention Grant
- Patent Title: Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
-
Application No.: US15547069Application Date: 2016-02-01
-
Publication No.: US11326210B2Publication Date: 2022-05-10
- Inventor: Shivani Shrivastava , Rakesh K Srivastava
- Applicant: GLAX LLC
- Applicant Address: US DE Wilmington
- Assignee: GLAX LLC
- Current Assignee: GLAX LLC
- Current Assignee Address: US DE Wilmington
- International Application: PCT/IB2016/050495 WO 20160201
- International Announcement: WO2016/120853 WO 20160804
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07H21/02 ; C12Q1/6886 ; G01N33/574 ; A61K31/7052 ; C12Q1/6883 ; A61K31/713 ; A61K45/06 ; C12N15/113
Abstract:
The present invention relates to the field of cancer and inflammation, and in particular methods of monitoring, diagnosis, prognosis, detecting, treating and preventing cancer and inflammation conditions. The use of composition comprises method of monitoring, diagnosis, prognosis, and detecting cancer and inflammation with EN2 and/or SATB2 expression and/or activity. The pharmaceutical composition will further comprise agents that inhibit EN2 and/or SATB2 expression or activity.
Public/Granted literature
- US20180010195A1 COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, PROGNOSIS, DETECTION, AND TREATMENT OF CANCER Public/Granted day:2018-01-11
Information query
